Daily Stock Market News

Ventilator recall and profit warning double whammy slam Philips


  • Philips says chips shortage hit Q4 profit and sales
  • Takes new 225 mln euros provision for ventilator recall
  • Shares drop 15% on worst day since 1998

AMSTERDAM, Jan 12 (Reuters) – Shares in Philips (PHG.AS) plunged 15% on Wednesday, their worst intra-day drop in over 20 years, after the Dutch health technology group warned supply chain woes would hit profits and a ventilator recall needed to be expanded.

Philips recalled upto 4 million of its breathing-aid machines last year amid concerns that a type of foam used in the devices could degrade and become toxic. It has now raised that estimate by 1 million and hiked its provision for the recall by 45% to 725 million euros. read more

“The extended recall is a major negative as this also extends the litigation risk”, ING analyst Marc Hesselink said.

Register now for FREE unlimited access to Reuters.com

The current provision does not cover the possible costs of litigation, with Philips facing more than a hundred class action suits. Fears of a large claims bill had already lopped around 15 billion euros off Philips’ market value in the past nine months.

In addition to the expanded recall, Philips also cut its estimate for adjusted earnings before interest, tax and amortisation (EBITA) by almost 40% in the fourth quarter to about 650 million euros ($739 million), as it continued to scramble for memory chips and other parts.

Philips Healthcare headquarters is seen in Best, Netherlands August 30, 2018. REUTERS/Piroschka van de Wouw

The double whammy of bad news saw it lose over 4.5 billion euros ($5.1 billion) of its market value, its worst day on the stock market since 1998, when it was still a sprawling conglomerate selling lightbulbs, televisions and CD-players.

Now specializing in medical equipment and other health products, Philips initially benefited from a jump in demand during the COVID-19 pandemic but a global shortage of semiconductors and other electronic components has left it exposed.

Chief Executive Frans van Houten said those shortages had put a serious brake on sales in recent months.

“We had shortages of several components and saw port congestion, sometimes up to 2 or 3 weeks. All of this meant our manufactured goods couldn’t reach customers in time”, he said.

Comparable sales fell 10% on a yearly basis to 4.9 billion euros, Philips said, as hospitals had to postpone the installation of equipment due to a lack of parts.

($1 = 0.8765 euros)

Register now for FREE unlimited access to Reuters.com

Reporting by Bart Meijer Editing by Subhranshu Sahu, Mark Potter and Carmel Crimmins

Our Standards: The Thomson Reuters Trust Principles.



Read More: Ventilator recall and profit warning double whammy slam Philips

You might also like
A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.